Navigation Links
Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2
Date:5/23/2013

que los operadores del mundo real tienen la oportunidad de usar esas tecnología complementarias, creo que quedarán impresionados".

También se anunció en EuroPCR 2013 el estudio investigador SYNTAX2, que será co-patrocinado por Volcano y Boston Scientific Corporation. SYNTAX2 está diseñado para controlar la precisión de la intervención coronaria percutánea guiada (PCI), utilizando un centro SYNTAX clínico como derivado en Cardialysis en Rótterdam junto con medidas iFR®/FFR Hybrid en vivo de los vasos para determinar qué pacientes y lesiones son tratados. Los stents liberadores de fármaco Boston Scientific SYNERGY™ serán puestos con la guía IVUS, empleando ambos dispositivos, de Volcano y Boston Scientific IVUS, para proporcionar un emplazamiento más preciso que el demostrado solo con angiografía.  

"El diseño y técnicas del stent moderno han mejorado drásticamente desde que se realizó el primer estudio SYNTAX hace más de cinco años," dijo el profesor Patrick Serruys , Rótterdam, Países Bajos. "En la comunidad se cree que PCI es una excelente alternativa a la cirugía de bypass coronario en los pacientes adecuados. El estudio SYNTAX2 usará un nuevo 'centro SYNTAX clínico' para identificar a los pacientes prospectivos que creemos se beneficiarán de un procedimiento PCI menos invasivo, y así usar fisiología y guía IVUS junto con la tecnología moderna de stent liberador de fármaco. El objetivo es mostrar que el entregar el PCI más preciso y moderno posible permitirá que más pacientes sean tratados con esta excelente alternativa a la cirugía bypass". 

"El hecho de que iFR haya sido validado en más de 3.000 pacientes como parte de esos estudios nos hace sentirnos cómodos en nuestra comprensió
'/>"/>

SOURCE Volcano Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Volcano Corporation Presentation At JMP Securities Conference To Be Webcast
2. Volcano to Highlight its Leadership in Precision Guided Therapy at EuroPCR 2012
3. Volcano Corporation Presentation At Jefferies Conference To Be Webcast
4. Volcano Corporation Presentation at Wells Fargo Conference to be Webcast
5. Volcano Corporation Schedules Second Quarter Conference Call, Webcast
6. Volcano Corporation Reports 13 Percent Growth In Second Quarter Revenues; FFR Disposable Revenues Increase 38 Percent
7. Volcano Corporation Presentation At Canaccord Genuity Conference To Be Webcast
8. FAME 2 Published in the New England Journal of Medicine, Volcano participates in the $84M NIH-Sponsored ISCHEMIA Trial
9. Volcano Corporation Presentation At Stifel Nicolaus Conference To Be Webcast
10. Volcano Announces Previous St. Jude Medical Products Infringe Volcano Patent and Jury Verdicts in Patent Trials with St. Jude Medical
11. Volcano Corporation Schedules Third Quarter Conference Call, Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Jan. 15, 2014  Humberto C. Antunes,  Galderma  worldwide CEO, ... the Journal of Drugs in Dermatology (JDD) ... (ODAC). The event is January 17-20, 2014, at the Omni Orlando ... The ODAC is a distinguished event ...
(Date:1/15/2014)... 2014  In an unprecedented effort to curb the spread of "superbugs" ... transport vehicles, an advanced and portable UV germicidal lamp manufactured by ... time. In order to prevent EMS paramedics and ... West Palm Beach Fire Rescue is the first ...
(Date:1/15/2014)... Jan. 15, 2014  Echo Therapeutics, Inc. (Nasdaq: ... Symphony® CGM System as a non-invasive, wireless continuous glucose ... , Executive Chairman and Interim CEO of Echo Therapeutics, ... Annual Equity Conference. Mr. Doman will ...
Breaking Medicine Technology:Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4Superbugs No Longer Ride In Rescue Vehicles 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3
(Date:4/23/2014)... and accessible detection methods that can rapidly screen ... a single cell inside that population has been ... Lu. , In the Royal Society of Chemistry ... that he and his coworkers have developed a ... a protein ( Chem. Sci. , 2014, DOI: ...
(Date:4/23/2014)... and vegetables are often displayed in the popular ... also plenty of high-sugar foods. A new study ... is portrayed in children,s TV programmes as well ... dietary habits and weight status. , Steingerdur Olafsdottir,s ... in the popular Swedish children,s TV show Bolibompa. ...
(Date:4/23/2014)... scientists led by a researcher from the Cancer Science ... of Singapore has identified the cancer specific stem cell ... possibility of developing new drugs for the treatment of ... research group, led by Dr Chan Shing Leng, Research ... time that a cancer-specific variant of a cell surface ...
(Date:4/23/2014)... research, published in the journal Oncotarget , ... different appearances or their own DNA signatures within ... difficult to design effective, targeted treatment strategies. , ... EGFR mutation and either the KRAS or BRAF ... by the EGFR gene mutation have that specific ...
(Date:4/23/2014)... of Alzheimer,s disease has been a rapidly evolving ... the latest crook in the research road, scientists ... between proteins associated with the disease. The report, ... Neuroscience , could have important implications for developing ... and colleagues explain that for years, research has ...
Breaking Medicine News(10 mins):Health News:Following a protein's travel inside cells is key to improving patient monitoring, drug development 2Health News:High-calorie and low-nutrient foods in kids' TV 2Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 2Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 3Health News:Non-uniform genetic mutations identified in lung cancers could lead to targeted treatment 2
... 8 ChildCare Education Institute (CCEI), a distance training institution ... give professional development training hours to ... child care providers can log in to CCEI,s learning management ... 2009 and May 15th, 2009 and receive five (5) hours ...
... Income Rises 172% to Record $2.3 MillionCHICAGO, May 8 Second quarter highlights: , ... Increase to $2.3 Million , Gross Profit Margin ... 46% Gross Profit Increase , ... , Year-to-date highlights: , , , ...
... Valeant Pharmaceuticals International (NYSE: VRX ) ... held company located in Poland for approximately $28 million. ... Poland into multiple therapeutic categories. EMO-FARM has a strong ... portfolio of currently marketed products and additional products under ...
... Ohio, May 8 James "Buster" Douglas, former ... President Obama in his brand new inspirational diabetic ... said, in "Buster,s Backyard Bar-B-Q Knockout Diabetes Diet," ... Kindle versions in time to order for Mother,s ...
... During May,s "National Brain Tumor Awareness Month"WASHINGTON, May 8 ... the sad news of his brother,s death from a brain ... of loss -- over 200,000 people will be diagnosed with ... an effort to bring awareness and ultimately find a cure, ...
... have less cardiovascular disease than those who smoke, ... men and women in Norway. Smoking, say the ... mortality from various causes. , The results, presented ... other studies have indicated, but, says investigator Professor ...
Cached Medicine News:Health News:ChildCare Education Institute Gives Child Care Staff Access to Professional Development Courses in Honor of Provider Appreciation Day, May 8th 2Health News:The Female Health Company Reports 67% Increase in Second Quarter Earnings 2Health News:The Female Health Company Reports 67% Increase in Second Quarter Earnings 3Health News:The Female Health Company Reports 67% Increase in Second Quarter Earnings 4Health News:The Female Health Company Reports 67% Increase in Second Quarter Earnings 5Health News:The Female Health Company Reports 67% Increase in Second Quarter Earnings 6Health News:The Female Health Company Reports 67% Increase in Second Quarter Earnings 7Health News:The Female Health Company Reports 67% Increase in Second Quarter Earnings 8Health News:The Female Health Company Reports 67% Increase in Second Quarter Earnings 9Health News:Valeant to Acquire Polish Dermatology Company 2Health News:President Obama's New Knockout Mother's Day Message from Champ 2Health News:Grey Ribbon Crusade(TM) Promotes National Unification in the Fight Against Brain Tumors 2Health News:30-year follow-up study: 'Tremendous' impact of smoking on mortality and cardiovascular disease 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: